6th Emerging Frontiers in Oncology Summit

Greenberg Traurig is a sponsor of the 6th Annual Emerging Frontiers in Oncology Summit on March 21 in Massachusetts. The summit will focus on new modalities beyond cell therapy for oncology and the drivers of future breakthroughs in oncology across research, innovation, and people. The summit will also discuss what is required to improve the translation of the future oncology pipeline. Greenberg Traurig Shareholder Prashant Girinath, Ph.D. will moderate the innovation debate-style panel "How much complexity is necessary? How much is feasible?"